With Christmas just four days away, holiday shoppers are flocking to the stores and malls on the hunt for deals. GOP members face backlash after defying Trump Actor James Ransone, who starred in 'The ...

(Bloomberg) --The holiday-shortened week started with gains in stocks amid a broad advance that saw a continuation of the bullish momentum on Wall Street. Oil and gold rallied as the dollar fell.

Italian computer metal outfit Master Boot Record are coming out to the U.S. next spring, bringing their metal instrumentals meets retro video game soundscape to our part of the globe. Having just ...

It’s a Syracuse holiday tradition that never gets old. Volunteers gather early on a frosty December morning to load boxes and bags onto a delivery truck. The man of the hour accepts congratulations on ...

This Christmas and New Year's holiday period is expected to be the busiest on record. More than 122 million people are expected to travel between Dec. 20 and Jan. 1 -- a 2.2% jump from last year's ...

The construction industry ranked among the strongest sectors for job growth in November, adding an estimated 28,000 positions overall in November, according to the Bureau of Labor Statistics' Dec. 16 ...

Detroit Lions wide receiver Amon-Ra St. Brown has etched his name into the NFL history books. A fourth-round pick of the Lions in 2021, St. Brown has been a staple of consistency since the team added ...

Consumers spent a record $6.4 billion online during Thanksgiving, driven in part by a surge in discounts. Spending increased 5.3% compared with a year ago, as shoppers took advantage of Cyber Week ...

★★★★☆ Add a terabyte of storage to your older MacBook with this affordable SSD. Photo: Ed Hardy/Cult of Mac Sandisk gives its new Extreme Fit USB-C Flash Drive the crown as “the world’s smallest 1TB ...

Rio Tinto Group is imposing surcharges on aluminum shipments it sells to the US, a move that threatens to further disrupt a North American market already roiled by import tariffs that are driving up ...

Becoming a blockbuster in its third full year on the market put Gilead’s cancer treatment Trodelvy on a course to potentially justify the company’s $21 billion buyout of Immunomedics in 2020. But ...